We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Won’t Enforce FMT IND Requirement for Clinical Use
FDA Won’t Enforce FMT IND Requirement for Clinical Use
July 17, 2013
The FDA says it will use discretion in regulating fecal microbiota transplantation (FMT) in clinical use, after stakeholders raised alarms that agency policy could hurt patients by limiting treatment.